Joon Lee
Stock Analyst at Truist Securities
(4.69)
# 107
Out of 4,792 analysts
117
Total ratings
57.14%
Success rate
39.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $79.66 | +88.30% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $6.91 | +624.11% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $33.28 | +155.41% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $108.01 | +85.17% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $32.76 | +266.30% | 5 | Feb 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $460 → $520 | $486.68 | +6.85% | 3 | Feb 11, 2025 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $18 | $1.97 | +812.55% | 1 | Jan 29, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $660 → $700 | $588.53 | +18.94% | 12 | Jan 14, 2025 | |
| VRNA Verona Pharma | Reiterates: Buy | $44 → $57 | $58.42 | -2.42% | 6 | Jan 8, 2025 | |
| SLDB Solid Biosciences | Initiates: Buy | $16 | $3.40 | +370.59% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $6.69 | +438.52% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $24.13 | +49.19% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.12 | +614.29% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $8 | $7.38 | +8.47% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $6.14 | +176.87% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $67.46 | +33.42% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $3.99 | +902.33% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $24.17 | +396.48% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $6.91 | +840.67% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $121.10 | +65.15% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $1.27 | +295.26% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.13 | +475.08% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.49 | +11,144.98% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $19.28 | +76.35% | 1 | Mar 16, 2021 |
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $79.66
Upside: +88.30%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $6.91
Upside: +624.11%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $33.28
Upside: +155.41%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $108.01
Upside: +85.17%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $32.76
Upside: +266.30%
Vertex Pharmaceuticals
Feb 11, 2025
Maintains: Buy
Price Target: $460 → $520
Current: $486.68
Upside: +6.85%
Larimar Therapeutics
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $1.97
Upside: +812.55%
argenx SE
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $588.53
Upside: +18.94%
Verona Pharma
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $58.42
Upside: -2.42%
Solid Biosciences
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $3.40
Upside: +370.59%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $6.69
Upside: +438.52%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $24.13
Upside: +49.19%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.12
Upside: +614.29%
Oct 30, 2024
Maintains: Hold
Price Target: $13 → $8
Current: $7.38
Upside: +8.47%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.14
Upside: +176.87%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $67.46
Upside: +33.42%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $3.99
Upside: +902.33%
Jun 17, 2024
Maintains: Buy
Price Target: $120
Current: $24.17
Upside: +396.48%
Mar 25, 2024
Reiterates: Buy
Price Target: $65
Current: $6.91
Upside: +840.67%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $121.10
Upside: +65.15%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.27
Upside: +295.26%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.13
Upside: +475.08%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.49
Upside: +11,144.98%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $19.28
Upside: +76.35%